Inventaire - dine venner og fællesskaber er dit bedste bibliotek - Inventaire

Relation of circulating liver transaminase concentrations to risk of new-onset atrial fibrillation

forfatter

Emelia J. Benjamin

Audrey Calderwood

Michiel Rienstra

Lisa M Sullivan

Michael J Pencina

Ramachandran S. Vasan

Caroline S Fox

Patrick T Ellinor

Moritz F Sinner

João T Fontes

Jared W Magnani

udgivet i: American Journal of Cardiology

dato for udgivelse: 2012-11-02

sprog: engelsk

main subject: atrieflimren

Cites articles 27

Date

Titel

Forfattere

2012-03-08

Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
2011-03-01

Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease
2011-06-01

Elevation of liver enzymes within the normal limits and metabolic syndrome

Ming-Feng Xia, Xin Gao
2010-11-01

Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation

Christopher Newton-Cheh, Pyotr G Platonov, Gunnar Engström, Olle Melander, Peter Almgren, Jan Gustav Smith, Joachim Struck, Nils G. Morgenthaler, Thomas J. Wang
2010-03-18

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey

Gregory Y. H. Lip, Deirdre A Lane, Harry J. G. M. Crijns, Ron Pisters, Robby Nieuwlaat
2010-01-04

Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community

Emelia J. Benjamin, Lisa M Sullivan, Michael J Pencina, Martin G Larson, Philip A Wolf, Ramachandran S. Vasan, James B. Meigs, Renate B. Schnabel, Patrick T Ellinor, Jacob Selhub, Thomas J. Wang, Jennifer M Yamamoto, Jared W Magnani, Geoffrey H Tofler
2009-02-01

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study

Lisa M Sullivan, Joseph M Massaro, Emelia J. Benjamin, Christopher Newton-Cheh, Michael J Pencina, Philip A Wolf, Ramachandran S. Vasan, Renate B. Schnabel, Patrick T Ellinor, Thomas J. Wang, Ralph B D'Agostino Jr, Jennifer M Yamamoto, Jared W Magnani, Thomas M Tadros
2009-02-01

Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program

Christopher B. Granger, Karl Swedberg, Salim Yusuf, Gary Felker, John McMurray, Marc A Pfeffer, Eric L Michelson, Duolao Wang, Larry A Allen, CHARM Investigators and Committees
2009-09-26

Abnormal liver function in relation to hemodynamic profile in heart failure patients

André P van Beek
2008-09-20

Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease

Wolfram Goessling, Joseph M Massaro, Ramachandran S. Vasan, Caroline S Fox, Ralph B. D'Agostino, Robert Curtis Ellison
2008-08-11

Pancytopenia and atrial fibrillation associated with chronic hepatitis C infection and presumed hepatocellular carcinoma: a case report
2008-01-30

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

Ramachandran S. Vasan, Michael J Pencina
2008-01-01

Incidence and prevalence of abnormal liver associated enzymes in patients with atrial fibrillation in a routine clinical care population

James D Lewis
2007-01-01

Antiarrhythmics: elimination and dosage considerations in hepatic impairment
2006-08-01

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiolog

Valentín Fuster Carulla, Juan Tamargo, Marco Metra, Alice K. Jacobs, American College of Cardiology, Heart Rhythm Society, Elliott M Antman, Jonathan L. Halperin, Kenneth Dickstein, European Heart Rhythm Association, Sidney C Smith, Kenneth A. Ellenbogen, Barbara Riegel, Andrzej Budaj, Jean-Yves Le Heuzey, A. John Camm, Harry J. G. M. Crijns, Eric N Prystowsky, Cynthia R Adams, Joseph P. Ornato, John Lekakis, David S Cannom, L Samuel Wann, Jeffery B Anderson, Rick Nishimura, Silvia Priori, Jaap W Deckers, Catherine Despres, Keith McGregor, Ady Osterspey, Jose Luis Zamorano, European Society of Cardiology Committee for Practice Guidelines
2005-01-01

Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease

Viola Vaccarino, Arshed A Quyyumi
2004-07-01

Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation.

Michael J Pencina
2003-10-01

Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease

Søren Møller
2003-07-01

B-type natriuretic peptide in cardiovascular disease.

Darren K McGuire, James A. de Lemos
2002-04-18

Nonalcoholic fatty liver disease
2002-10-01

American Gastroenterological Association medical position statement: evaluation of liver chemistry tests
2000-02-01

Serum aminotransferase concentration as evidence of hepatocellular damage
1994-03-01

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study

Emelia J. Benjamin
1993-07-01

Survival after the onset of congestive heart failure in Framingham Heart Study subjects
1986-07-01

Serum mitochondrial aspartate aminotransferase as a marker of chronic alcoholism: diagnostic value and interpretation in a liver unit

Bertrand Nalpas
1978-11-01

Aspartate aminotransferase activity and isoenzyme proportions in human liver tissues

Robert Rej
1951-03-01

Epidemiological approaches to heart disease: the Framingham Study

Artikel - wd:Q36514049

Welcome to Inventaire

dit venne- og fællesskabs bibliotek

vil du vide mere

you are offline